Marshall Wace, LLP Royalty Pharma PLC Transaction History

Marshall Wace, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $13.4 Million - $15.3 Million	-510,060 Reduced 35.03%	945,840 $24.9 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $435,433 - $496,799	15,857 Added 1.1%	1,455,900 $44.2 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $33.4 Million - $37.3 Million	1,275,233 Added 773.76%	1,440,043 $40.5 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $43.1 Million - $51.5 Million	-1,641,811 Reduced 90.88%	164,810 $4.47 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $33.6 Million - $41.5 Million	1,134,091 Added 168.63%	1,806,621 $55.5 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $22 Million - $26.5 Million	672,530 New	672,530 $24.2 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $17.2 Million - $19.3 Million	432,250 New	432,250 $17.4 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $2.8 Million - $3.3 Million	-74,655 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $4.35 Million - $4.93 Million	-116,191 Reduced 60.88%	74,655 $2.91 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $35.6 Million - $43 Million	-1,011,134 Reduced 84.12%	190,846 $7.61 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $43.4 Million - $50.8 Million	1,201,980 New	1,201,980 $43.4 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $1.06 Million - $1.46 Million	-29,255 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $1.13 Million - $1.41 Million	29,255 New	29,255 $1.23 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.